{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Cancer cell",
      "Cancer stroma",
      "Induction therapy",
      "Non-small cell lung cancer"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "27640003",
  "DateCompleted": {
    "Year": "2017",
    "Month": "02",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2016",
        "Month": "09",
        "Day": "17"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00432-016-2271-8"
    ],
    "Journal": {
      "ISSN": "1432-1335",
      "JournalIssue": {
        "Volume": "143",
        "Issue": "2",
        "PubDate": {
          "Year": "2017",
          "Month": "Feb"
        }
      },
      "Title": "Journal of cancer research and clinical oncology",
      "ISOAbbreviation": "J Cancer Res Clin Oncol"
    },
    "ArticleTitle": "The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer.",
    "Pagination": {
      "StartPage": "215",
      "EndPage": "223",
      "MedlinePgn": "215-223"
    },
    "Abstract": {
      "AbstractText": [
        "Induction therapy induces degenerative changes of various degrees in both cancerous and non-cancerous cells of non-small cell lung cancer (NSCLC). The effect of induction therapy on histological characteristics, in particular the ratio of residual cancer cells to non-cancerous components, is unknown.",
        "Seventy-four NSCLC patients treated with induction therapy followed by surgery were enrolled. Residual cancer cells were identified using anti-pan-cytokeratin antibody (AE1/AE3). We analyzed and quantified the following three factors via digital image analysis; (1) the tumor area containing cancer cells and non-cancerous components (TA), (2) the total area of AE1/AE3 positive cancer cells (TACC), (3) the percentage of TACC to TA (%TACC). These factors were also analyzed in a matched control group (surgery alone, n\u00a0=\u00a080).",
        "The median TACC of the induction therapy group was significantly lower than that of the control group (p\u00a0<\u00a00.01). In addition, the median %TACC of the induction therapy group (5.9\u00a0%) was significantly lower than that of the control group (58.6\u00a0%) (p\u00a0<\u00a00.01). TACC had a strong positive correlation with TA in the control group (r\u00a0=\u00a00.93), but not in the induction therapy group. Conversely, TACC had a strong positive correlation with %TACC in the induction therapy group (r\u00a0=\u00a00.95), but not in the control group.",
        "Unlike the control group, the smaller the total area of residual cancer cells, the higher residual tumor contained non-cancerous components in the induction group, which may be the characteristic histological feature of NSCLC after induction therapy."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya, Aichi, Japan."
          }
        ],
        "LastName": "Goto",
        "ForeName": "Masaki",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Naito",
        "ForeName": "Masahito",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Saruwatari",
        "ForeName": "Koichi",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Hisakane",
        "ForeName": "Kakeru",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          }
        ],
        "LastName": "Kojima",
        "ForeName": "Motohiro",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          }
        ],
        "LastName": "Fujii",
        "ForeName": "Satoshi",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          }
        ],
        "LastName": "Kuwata",
        "ForeName": "Takeshi",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan."
          }
        ],
        "LastName": "Ochiai",
        "ForeName": "Atsushi",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biostatistics Division, Center for Research Administration and Support, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Nomura",
        "ForeName": "Shogo",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Aokage",
        "ForeName": "Keiju",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Hishida",
        "ForeName": "Tomoyuki",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Yoshida",
        "ForeName": "Junji",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya, Aichi, Japan."
          }
        ],
        "LastName": "Yokoi",
        "ForeName": "Kohei",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Thoracic Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan."
          }
        ],
        "LastName": "Tsuboi",
        "ForeName": "Masahiro",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. gishii@east.ncc.go.jp."
          }
        ],
        "LastName": "Ishii",
        "ForeName": "Genichiro",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "J Cancer Res Clin Oncol",
    "NlmUniqueID": "7902060",
    "ISSNLinking": "0171-5216"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "mortality",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"
    },
    {
      "QualifierName": [
        "mortality",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Carcinoma, Non-Small-Cell Lung"
    },
    {
      "QualifierName": [
        "mortality",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Carcinoma, Squamous Cell"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Count"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Chemoradiotherapy, Adjuvant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Induction Chemotherapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Kaplan-Meier Estimate"
    },
    {
      "QualifierName": [
        "mortality",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Proportional Hazards Models"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Stromal Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tumor Burden"
    }
  ]
}